INSM Insmed Incorporated - Common Stock
$128,81
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$90–$213
31% of range
تقييم المحللين
BUY
30 analysts
السعر المستهدف
$200
+55% upside
P/E (TTM)
-20.3
ROE
-128.4%
هامش صافي الربح
-210.5%
INSM لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$128.81
القيمة السوقية
$27.89B
P/E (TTM)
-20.3
ربح السهم (آخر 12 شهرًا)
$-6.42
الإيرادات (آخر 12 شهرًا)
$606M
عائد التوزيعات
—
ROE
-128.4%
D/E الدين/حقوق الملكية
0.7
نطاق 52 أسبوعًا
$90 – $213
INSM مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$606M
2016-12-31
→
2025-12-31
ربح السهم
$-6.42
2019-12-31
→
2025-12-31
التدفق النقدي الحر
$-968M
2016-12-31
→
2025-12-31
الهوامش
-210.5%
2019-12-31
→
2019-12-31
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
INSM
متوسط الأقران
P/E (TTM)
-20.3
17.7
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
46.0
6.8
P/B (السعر / القيمة الدفترية)
37.7
6.4
EV / EBITDA
-21.7
—
Price / FCF (السعر / التدفق النقدي الحر)
-28.8
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
INSM
متوسط الأقران
Operating Margin (هامش التشغيل)
-205.6%
—
Net Profit Margin (هامش صافي الربح)
-210.5%
20.3%
ROA (العائد على الأصول)
-59.5%
11.4%
ROE
-128.4%
16.8%
ROIC
-97.8%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
INSM
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
0.7
—
Current Ratio (النسبة الحالية)
3.8
3.4
Quick Ratio (النسبة السريعة)
3.4
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
INSM
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
66.7%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
35.2%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
29.8%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
INSM
متوسط الأقران
INSM توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
30 محللين
- شراء قوي 9 30,0%
- شراء 20 66,7%
- احتفاظ 1 3,3%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
22 محللين · 2026-08-18
الوسيط
$197.50
← أقل من جميع الأهداف
$128.81
منخفض
$169.00
مرتفع
$243.00
السعر المستهدف الوسيط
$197.50
+53,3%
السعر المستهدف المتوسط
$200.05
+55,3%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
-0.02%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.06 | $-0.80 | 0.74% |
| 31 مارس، 2026 | $-0.76 | $-0.98 | 0.22% |
| 31 ديسمبر، 2025 | $-1.54 | $-1.32 | -0.22% |
| 30 سبتمبر، 2025 | $-1.75 | $-1.37 | -0.38% |
| 30 يونيو، 2025 | $-1.70 | $-1.32 | -0.38% |
| 31 مارس، 2025 | $-1.42 | $-1.36 | -0.06% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| RVMD | — | — | — | — | — | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | · | |
| Cost of Revenue | $123M | $86M | $66M | $55M | $44M | $40M | $24M | $2M | $0 | $0 | · | · | |
| Gross Profit | · | · | · | · | · | · | $112M | $7M | $0 | · | · | · | |
| R&D Expense | $771M | $598M | $571M | $398M | $273M | $181M | $132M | $145M | $110M | $123M | $74M | $56M | |
| SG&A Expense | $701M | $461M | $345M | $266M | $234M | $204M | $211M | $168M | $79M | $51M | $43M | $31M | |
| Operating Expenses | $1.85B | $1.24B | $1.01B | $703M | $564M | $430M | $372M | $317M | $189M | $173M | $117M | $87M | |
| Operating Income | $-1.25B | $-878M | $-710M | $-457M | $-375M | $-265M | $-235M | $-307M | $-189M | $-173M | $-117M | $-87M | |
| Interest Expense | $84M | $85M | $82M | $26M | $40M | $30M | $28M | $25M | $6M | $3M | $3M | $2M | |
| Other Non-op | $-2M | $29.0K | $2M | $-6M | $-3M | $405.0K | $-531.0K | $602.0K | $300.0K | $119.0K | $-33.0K | $141.0K | |
| Pretax Income | $-1.27B | $-910M | $-747M | $-480M | $-436M | $-293M | $-254M | $-324M | $-193M | $-176M | $-120M | $-90M | |
| Income Tax | $5M | $4M | $3M | $1M | $-2M | $1M | $777.0K | $201.0K | $-272.0K | $98.0K | $-2M | $-10M | |
| Net Income | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| EPS (Basic) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| Shares (Basic) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| Shares (Diluted) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| EBITDA | $-1.25B | $-878M | $-704M | $-452M | $-366M | $-256M | $-230M | $-304M | $-186M | $-171M | $-116M | · |
الميزانية العمومية 27
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $555M | $482M | $1.07B | $717M | $533M | $487M | $495M | $381M | $163M | $283M | $159M | |
| Short-term Investments | $920M | $879M | $298M | $74M | $0 | · | · | · | · | · | · | · | |
| Receivables | $141M | $52M | $41M | $30M | $24M | $17M | $19M | $6M | $0 | · | · | · | |
| Inventory | $132M | $99M | $83M | $70M | $67M | $50M | $28M | $7M | $0 | · | · | · | |
| Prepaid Expense | $91M | $37M | $24M | $25M | $29M | $24M | $20M | $11M | $8M | $6M | $5M | $5M | |
| Current Assets | $1.79B | $1.62B | $929M | $1.27B | $837M | $623M | $555M | $519M | $389M | $168M | $288M | $165M | |
| PP&E (Net) | $103M | $80M | $65M | $56M | $53M | $54M | $60M | $23M | $12M | $10M | $8M | $8M | |
| PP&E (Gross) | $164M | $130M | $110M | $96M | $90M | $82M | $79M | $37M | $23M | $18M | $13M | $11M | |
| Accum. Depreciation | $61M | $50M | $45M | $39M | $37M | $28M | $19M | $14M | $11M | $8M | $5M | $3M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $0 | · | · | · | · | · | · | |
| Intangibles | $98M | $59M | $64M | $69M | $74M | $49M | $54M | $59M | $58M | · | · | · | |
| Total Assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Accounts Payable | $80M | $73M | $65M | $50M | $36M | $43M | $13M | $18M | $15M | $10M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | $61M | $38M | $40M | $38M | $17M | $17M | $11M | $10M | |
| Current Liabilities | $469M | $298M | $226M | $190M | $135M | $119M | $85M | $80M | $45M | $28M | $22M | $20M | |
| Capital Leases | $12M | $9M | $11M | $15M | $21M | $21M | $29M | · | · | · | · | · | |
| Other Non-current Liabilities | $6M | $499.0K | $3M | $9M | $20M | $9M | $11M | $0 | $765.0K | $693.0K | $572.0K | $23.0K | |
| Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833M | $520M | $481M | $396M | $101M | $83M | $45M | $45M | |
| Long-term Debt | $547M | $1.12B | $1.18B | $1.15B | $800M | $450M | $450M | $450M | $55M | $55M | $25M | $25M | |
| Total Debt | $541M | $1.10B | $1.16B | $1.13B | $567M | $356M | $336M | $317M | $56M | $55M | $25M | · | |
| Common Stock | $2M | $2M | $1M | $1M | $1M | $1M | $897.0K | $773.0K | $766.0K | $620.0K | $618.0K | $498.0K | |
| Paid-in Capital | $6.37B | $4.65B | $3.11B | $2.78B | $2.67B | $2.11B | $1.80B | $1.49B | $1.32B | $919M | $900M | $657M | |
| Retained Earnings | $-5.64B | $-4.36B | $-3.45B | $-2.70B | $-2.27B | $-1.83B | $-1.54B | $-1.28B | $-958M | $-765M | $-589M | $-471M | |
| AOCI | $1M | $-2M | $-745.0K | $756.0K | $968.0K | $193.0K | $-10.0K | $-9.0K | $-3.0K | $-65.0K | · | · | |
| Stockholders' Equity | $739M | $285M | $-332M | $88M | $410M | $276M | $262M | $208M | $361M | $154M | $312M | $186M | |
| Liabilities + Equity | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Shares Outstanding | 214,255,853 | 179,383,000 | 147,978,000 | 135,654,000 | 118,738,000 | 102,763,060 | 89,682,387 | 77,307,521 | 76,610,508 | 62,019,889 | 61,813,995 | 49,806,131 |
التدفق النقدي 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $6M | $5M | $9M | $9M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Stock-based Comp | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | |
| Deferred Tax | $-27.0K | $-29.0K | $-54.0K | $-231.0K | $-3M | $0 | $0 | $0 | $-417.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $0 | $0 | · | · | |
| Other Non-cash | · | · | $133M | $18M | $20M | $29M | $-28M | $36M | $12M | $9M | $-89.0K | · | |
| Operating Cash Flow | $-935M | $-684M | $-536M | $-400M | $-363M | $-219M | $-251M | $-258M | $-160M | $-147M | $-101M | $-64M | |
| CapEx | $33M | $22M | $13M | $10M | $7M | $6M | $42M | $13M | $3M | $4M | $3M | $5M | |
| Investing Cash Flow | $-65M | $-583M | $-224M | $-35M | $-64M | $-7M | $-42M | $-15M | $-3M | $-4M | $-3M | · | |
| Stock Issued | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | $0 | $223M | $109M | |
| Net Stock Activity | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | · | $223M | · | |
| Financing Cash Flow | $954M | $1.34B | $168M | $793M | $613M | $271M | $285M | $387M | $381M | $31M | $228M | · | |
| Net Change in Cash | $-45M | $73M | $-592M | $357M | $184M | $45M | $-8M | $114M | $219M | $-120M | $124M | $45M | |
| Taxes Paid | $4M | $2M | $2M | $2M | $2M | $814.0K | $339.0K | $154.0K | $166.0K | $85.0K | $-3M | $9M | |
| Free Cash Flow | $-968M | $-706M | $-550M | $-410M | $-371M | $-226M | $-293M | $-271M | $-163M | $-151M | $-104M | · | |
| Levered FCF | $-1.05B | $-791M | $-632M | $-437M | $-411M | $-255M | $-321M | $-297M | $-169M | $-154M | $-107M | · |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 82.3% | · | · | · | · | · | |
| Operating Margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | · | · | · | · | |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | · | · | · | · | |
| Pretax Margin | -209.7% | -250.2% | -244.8% | -195.7% | -231.6% | -178.0% | -185.8% | -3295.1% | · | · | · | · | |
| EBITDA Margin | -205.6% | -241.5% | -230.7% | -184.2% | -194.2% | -155.8% | -168.6% | -3088.3% | · | · | · | · | |
| ROA | -59.5% | -54.5% | -50.2% | -33.2% | -42.6% | -38.2% | -37.8% | -60.8% | -55.0% | -59.3% | -40.2% | · | |
| ROE | -128.4% | -237.7% | 241.3% | -1660.7% | -95.0% | -92.9% | -89.9% | -129.8% | -74.7% | -75.6% | -47.5% | · | |
| ROIC | -97.8% | -63.5% | -86.5% | -37.8% | -38.2% | -42.1% | -39.5% | -58.6% | -45.3% | -82.9% | -34.3% | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 | 5.2 | 6.5 | 6.5 | 8.7 | 6.0 | 12.9 | · | |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 | 4.6 | 5.9 | 6.3 | 8.5 | 5.8 | 12.7 | · | |
| Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| LT Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| Interest Coverage | -14.9 | -10.3 | -8.7 | -17.3 | -9.3 | -9.0 | -8.5 | -12.1 | -31.9 | -49.6 | -40.7 | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.8 | 0.8 | 1.0 | 1.4 | 0.7 | · | · | · | · | |
| Receivables Turnover | 6.3 | 7.8 | 8.6 | 9.1 | 9.2 | 9.2 | 11.0 | 3.6 | · | · | · | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 66.7% | 19.2% | 24.4% | 30.2% | 14.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.2% | 24.5% | 22.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.8% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | $12M | |
| Net Income TTM | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| Market Cap | $37.29B | $12.38B | $4.59B | $2.71B | $3.23B | $3.42B | $2.14B | $1.01B | $2.39B | $821M | $1.12B | · | |
| Enterprise Value | $36.40B | $12.05B | $4.96B | $2.69B | $3.08B | $3.24B | $1.99B | $836M | $2.06B | $713M | $864M | · | |
| P/E | -27.1 | -12.4 | -5.8 | -5.1 | -7.0 | -11.1 | -7.9 | · | · | · | · | · | |
| P/S | 61.5 | 34.1 | 15.0 | 11.0 | 17.2 | 20.8 | 15.7 | 103.1 | · | · | · | · | |
| P/B | 50.5 | 43.4 | -13.8 | 30.8 | 7.9 | 12.4 | 8.2 | 4.9 | 6.6 | 5.3 | 3.6 | · | |
| P / Tangible Book | 73.8 | 136.7 | · | · | 16.1 | 15.1 | · | · | · | · | · | · | |
| P / Cash Flow | -39.9 | -18.1 | -8.6 | -6.8 | -8.9 | -15.6 | -8.5 | -3.9 | -15.0 | -5.6 | -11.1 | · | |
| P / FCF | -38.5 | -17.5 | -8.3 | -6.6 | -8.7 | -15.2 | -7.3 | -3.7 | -14.7 | -5.4 | -10.8 | · | |
| EV / EBITDA | -29.2 | -13.7 | -7.0 | -5.9 | -8.4 | -12.7 | -8.7 | -2.8 | -11.1 | -4.2 | -7.5 | · | |
| EV / FCF | -37.6 | -17.1 | -9.0 | -6.5 | -8.3 | -14.4 | -6.8 | -3.1 | -12.7 | -4.7 | -8.3 | · | |
| EV / Revenue | 60.0 | 33.1 | 16.3 | 11.0 | 16.4 | 19.7 | 14.6 | 85.0 | · | · | · | · | |
| Earnings Yield | -3.7% | -8.1% | -17.2% | -19.6% | -14.2% | -9.0% | -12.6% | · | · | · | · | · |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $425M | $306M | $264M | $142M | $107M | $93M | $104M | $93M | $90M | $76M | $84M | $79M | $77M | $65M | $59M | $68M | |
| Cost of Revenue | $67M | $47M | $44M | $29M | $28M | $21M | $26M | $21M | $21M | $17M | $18M | $17M | $17M | $14M | $13M | $13M | |
| R&D Expense | $210M | $209M | $255M | $186M | $177M | $153M | $180M | $151M | $147M | $121M | $137M | $109M | $197M | $128M | $125M | $100M | |
| SG&A Expense | $247M | $247M | $212M | $186M | $155M | $148M | $143M | $119M | $107M | $93M | $90M | $91M | $84M | $80M | $73M | $76M | |
| Operating Expenses | $427M | $459M | $584M | $508M | $420M | $341M | $335M | $307M | $379M | $221M | $262M | $227M | $313M | $213M | $211M | $195M | |
| Operating Income | $-2M | $-153M | $-320M | $-366M | $-313M | $-248M | $-230M | $-213M | $-289M | $-146M | $-178M | $-148M | $-236M | $-148M | $-151M | $-128M | |
| Interest Expense | · | · | · | · | $21M | $22M | $22M | $21M | $21M | $21M | $21M | $20M | $21M | $20M | $16M | $3M | |
| Other Non-op | $-531.0K | $-736.0K | $-2M | $-603.0K | $453.0K | $132.0K | $-445.0K | $2M | $-269.0K | $-1M | $2M | $285.0K | $-488.0K | $-111.0K | $1M | $-2M | |
| Pretax Income | $-11M | $-162M | $-327M | $-369M | $-320M | $-256M | $-234M | $-220M | $-300M | $-157M | $-185M | $-158M | $-244M | $-159M | $-160M | $-131M | |
| Income Tax | $2M | $1M | $2M | $1M | $1M | $912.0K | $1M | $1M | $838.0K | $589.0K | $998.0K | $544.0K | $530.0K | $483.0K | $125.0K | $372.0K | |
| Net Income | $-13M | $-164M | $-328M | $-370M | $-322M | $-257M | $-236M | $-221M | $-301M | $-157M | $-186M | $-159M | $-245M | $-160M | $-160M | $-131M | |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| Shares (Basic) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| Shares (Diluted) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| EBITDA | $-2M | $-153M | · | $-366M | $-313M | $-248M | · | $-213M | $-289M | $-146M | · | $-148M | $-236M | $-148M | · | $-128M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $582M | $510M | $335M | $1.28B | $403M | $555M | $461M | $1.25B | $596M | · | $487M | $613M | $969M | · | $415M | |
| Short-term Investments | $616M | $641M | $920M | $1.35B | $572M | $796M | $879M | $1.01B | $0 | $0 | · | $299M | $305M | $30M | · | $99M | |
| Receivables | $215M | $179M | $141M | $65M | $55M | $48M | $52M | $42M | $40M | $37M | · | $36M | $31M | $31M | · | $27M | |
| Inventory | $142M | $133M | $132M | $121M | $108M | $101M | $99M | $98M | $90M | $83M | · | $78M | $77M | $71M | · | $66M | |
| Prepaid Expense | $116M | $78M | $91M | $66M | $62M | $55M | $37M | $41M | $41M | $43M | · | $27M | $26M | $29M | · | $25M | |
| Current Assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | $1.40B | $1.62B | $1.65B | $1.42B | $759M | · | $927M | $1.05B | $1.13B | · | $632M | |
| PP&E (Net) | $107M | $103M | $103M | $90M | $90M | $88M | $80M | $75M | $73M | $69M | · | $65M | $62M | $60M | · | $54M | |
| PP&E (Gross) | $174M | $166M | $164M | $147M | $145M | $141M | $130M | $124M | $120M | $115M | · | $108M | $104M | $100M | · | $92M | |
| Accum. Depreciation | $67M | $64M | $61M | $57M | $55M | $52M | $50M | $49M | $47M | $46M | · | $43M | $42M | $41M | · | $38M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | · | $136M | $136M | $136M | · | $136M | |
| Intangibles | $93M | $96M | $98M | $85M | $56M | $57M | $59M | $60M | $61M | $62M | $64M | $65M | $66M | $67M | · | $70M | |
| Total Assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Accounts Payable | $75M | $73M | $80M | $80M | $74M | $58M | $73M | $65M | $51M | $44M | · | $65M | $56M | $57M | · | $12M | |
| Current Liabilities | $439M | $361M | $469M | $417M | $312M | $239M | $298M | $259M | $524M | $421M | · | $197M | $204M | $188M | · | $138M | |
| Capital Leases | $8M | $10M | $12M | $8M | $8M | $8M | $9M | $10M | $12M | $14M | · | $13M | $13M | $15M | · | $17M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $6M | $5M | $499.0K | $3M | $3M | $3M | · | $6M | $11M | $10M | · | $11M | |
| Total Liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | $1.70B | $1.74B | $1.57B | $1.77B | $1.62B | · | $1.61B | $1.59B | $1.56B | · | $1.02B | |
| Long-term Debt | $547M | $547M | $547M | $547M | $547M | $1.12B | · | $972M | $1.19B | $1.18B | · | $1.17B | $1.17B | $1.16B | · | $800M | |
| Total Debt | $544M | $542M | · | $540M | $539M | $1.11B | · | $955M | $1.17B | $1.16B | · | $1.15B | $1.14B | $1.13B | · | $785M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $6.57B | $6.50B | $6.37B | $6.25B | $6.18B | $4.71B | $4.65B | $4.61B | $3.94B | $3.14B | · | $2.97B | $2.95B | $2.81B | · | $2.51B | |
| Retained Earnings | $-5.81B | $-5.80B | $-5.64B | $-5.31B | $-4.94B | $-4.62B | $-4.36B | $-4.12B | $-3.90B | $-3.60B | · | $-3.26B | $-3.10B | $-2.86B | · | $-2.54B | |
| AOCI | $-3M | $4.0K | $1M | $2M | $2M | $-902.0K | $-2M | $547.0K | $-3M | $-2M | · | $-2M | $-1M | $1M | · | $-1M | |
| Stockholders' Equity | $757M | $705M | $739M | $946M | $1.25B | $99M | $285M | $483M | $39M | $-465M | $-332M | $-289M | $-156M | $-45M | $88M | $-30M | |
| Liabilities + Equity | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Shares Outstanding | 218,281,059 | 216,521,841 | 214,255,853 | 212,583,015 | 211,110,658 | 181,900,074 | 179,382,635 | 178,846,991 | 166,666,599 | 148,560,882 | 147,978,000 | 143,049,197 | 142,750,463 | 136,429,216 | 135,654,000 | 121,726,199 |
التدفق النقدي 12
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $46M | $39M | $31M | $43M | $39M | $27M | $26M | $23M | $21M | $20M | $20M | $18M | $16M | $15M | $16M | |
| Deferred Tax | $0 | $0 | $-27.0K | $0 | $0 | $0 | $-29.0K | $0 | $0 | $0 | $-54.0K | $0 | $0 | $0 | $-231.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-89M | $-223M | $-248M | $-220M | $-206M | $-262M | $-196M | $-181M | $-123M | $-184M | $-131M | $-136M | $-123M | $-146M | $-103M | $-90M | |
| CapEx | $6M | $3M | $17M | $2M | $3M | $10M | $7M | $4M | $7M | $5M | $2M | $3M | $5M | $3M | $5M | $582.0K | |
| Investing Cash Flow | $25M | $266M | $389M | $-762M | $228M | $80M | $132M | $-1.00B | $-7M | $295M | $2M | $7M | $-274M | $42M | $20M | $49M | |
| Stock Issued | · | · | $0 | $-256.0K | · | · | $-12.0K | $371M | · | · | $114M | $0 | · | · | $259M | $33M | |
| Financing Cash Flow | $27M | $30M | $34M | $33M | $858M | $29M | $159M | $397M | $781M | $3M | $123M | $1M | $44M | $-399.0K | $743M | $37M | |
| Net Change in Cash | $-37M | $72M | $176M | $-950M | $881M | $-152M | $94M | $-785M | $651M | $113M | $-5M | $-126M | $-356M | $-105M | $659M | $-1M | |
| Taxes Paid | $696.0K | $3M | $111.0K | $1M | $677.0K | $2M | $248.0K | $689.0K | $354.0K | $1M | $75.0K | $518.0K | $358.0K | $1M | $91.0K | $432.0K | |
| Free Cash Flow | · | $-226M | · | · | · | $-272M | · | · | · | $-189M | · | · | · | $-150M | · | · | |
| Levered FCF | · | · | · | · | · | $-294M | · | · | · | $-210M | · | · | · | $-170M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| Net Margin | -3.1% | -53.5% | · | -259.9% | -299.5% | -276.4% | · | -236.0% | -332.8% | -208.1% | · | -201.0% | -317.0% | -245.0% | · | -193.6% | |
| Pretax Margin | -2.7% | -53.0% | · | -259.0% | -298.3% | -275.4% | · | -235.0% | -331.8% | -207.3% | · | -200.3% | -316.3% | -244.2% | · | -193.1% | |
| EBITDA Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| ROA | -0.58% | -8.4% | · | -16.8% | -15.0% | -17.3% | · | -13.1% | -18.5% | -11.7% | · | -13.7% | -19.6% | -12.0% | · | -11.4% | |
| ROE | -1.3% | -40.7% | · | -51.8% | -49.9% | 140.3% | · | -227.3% | 514.2% | 61.7% | · | 99.6% | 439.1% | -424.7% | · | -55.2% | |
| ROIC | -0.14% | -12.4% | · | -24.7% | -17.6% | -20.7% | · | -14.9% | -23.9% | -20.9% | · | -17.3% | -24.0% | -13.7% | · | -17.0% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.5 | · | 4.6 | 6.7 | 5.9 | · | 6.4 | 2.7 | 1.8 | · | 4.7 | 5.2 | 6.0 | · | 4.6 | |
| Quick Ratio | 3.1 | 3.9 | · | 4.2 | 6.1 | 5.2 | · | 5.8 | 2.5 | 1.5 | · | 4.2 | 4.6 | 5.5 | · | 3.9 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 30.2 | -2.5 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 24.4 | -2.0 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| Interest Coverage | · | · | · | · | -14.7 | -11.5 | · | -10.1 | -13.6 | -6.9 | · | -7.3 | -11.4 | -7.4 | · | -38.1 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 3.1 | 2.7 | · | 2.6 | 2.3 | 2.2 | · | 2.4 | 2.5 | 2.2 | · | 2.5 | 2.6 | 2.3 | · | 2.9 |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $981M | $649M | · | $436M | $384M | $352M | · | $338M | $322M | $297M | · | $289M | $275M | $251M | · | $233M | |
| Net Income TTM | $-869M | $-1.11B | · | $-1.17B | $-1.10B | $-935M | · | $-837M | $-861M | $-721M | · | $-695M | $-631M | $-481M | · | $-434M | |
| Market Cap | $23.27B | $35.41B | · | $30.61B | $21.25B | $13.88B | · | $13.06B | $11.17B | $4.03B | · | $3.61B | $3.01B | $2.33B | · | $2.62B | |
| Enterprise Value | $22.66B | $34.72B | · | $29.47B | $19.93B | $13.78B | · | $12.54B | $11.09B | $4.60B | · | $3.97B | $3.23B | $2.46B | · | $2.89B | |
| P/E | -25.0 | -29.0 | · | -23.5 | -15.9 | -13.4 | · | -13.6 | -11.4 | -5.3 | · | -4.9 | -4.4 | -4.4 | · | -5.9 | |
| P/S | 23.7 | 54.6 | · | 70.2 | 55.3 | 39.4 | · | 38.6 | 34.7 | 13.6 | · | 12.5 | 10.9 | 9.3 | · | 11.3 | |
| P/B | 30.7 | 50.2 | · | 32.4 | 17.0 | 139.9 | · | 27.0 | 287.7 | -8.7 | · | -12.5 | -19.3 | -52.1 | · | -87.5 | |
| P / Tangible Book | 44.1 | 74.8 | · | 42.2 | 20.1 | · | · | 45.4 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -159.0 | · | · | · | -52.9 | · | · | · | -21.9 | · | · | · | -15.9 | · | · | |
| P / FCF | · | -156.5 | · | · | · | -51.0 | · | · | · | -21.4 | · | · | · | -15.5 | · | · | |
| EV / EBITDA | -14635.9 | -226.5 | · | -80.5 | -63.7 | -55.5 | · | -58.8 | -38.4 | -31.6 | · | -26.9 | -13.7 | -16.6 | · | -22.7 | |
| EV / FCF | · | -153.5 | · | · | · | -50.6 | · | · | · | -24.4 | · | · | · | -16.4 | · | · | |
| EV / Revenue | 23.1 | 53.5 | · | 67.6 | 51.9 | 39.1 | · | 37.1 | 34.4 | 15.5 | · | 13.7 | 11.7 | 9.8 | · | 12.4 | |
| Earnings Yield | -4.0% | -3.4% | · | -4.3% | -6.3% | -7.5% | · | -7.4% | -8.8% | -18.9% | · | -20.4% | -22.9% | -22.6% | · | -17.0% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $606M | $364M | $305M | $245M | $188M |
| هامش الربح التشغيلي % | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% |
| صافي الدخل | $-1.28B | $-914M | $-750M | $-482M | $-435M |
| EPS المخفف | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 |
| النسبة الحالية | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 |
| النسبة السريعة | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-968M | $-706M | $-550M | $-410M | $-371M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
- Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
- ضغوط تنافسية تدفع Truist لخفض السعر المستهدف لـ Insmed (INSM)
- الرئيس التنفيذي لشركة Insmed يكشف أن عدد المرضى في اليابان يتجاوز سوق الولايات المتحدة لمرض الرئة
- تم بيع صندوق الأسهم الصغيرة الحرفي لشركة Insmed (INSM) بناءً على اعتبارات التقييم
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 753 مقدمي إقرار · $16.3B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 137 (+28 مقابل الربع السابق) | 113 (+21 مقابل الربع السابق) | 248 (-30 مقابل الربع السابق) | 231 (+3 مقابل الربع السابق) | +38.4M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| FMR LLC | $1246915143 | 11694946 | 7,63% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1109696908 | 10407962 | 6,79% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $1043902026 | 9790865 | 6,38% | الأسهم |
| BAKER BROS. ADVISORS LP | $937841355 | 8796111 | 5,74% | الأسهم |
| Capital International Investors | $878338960 | 8238124 | 5,37% | الأسهم |
| Darwin Global Management, Ltd. | $673600013 | 6431163 | 4,12% | الأسهم |
| STATE STREET CORP | $645282792 | 6052174 | 3,95% | الأسهم |
| Artisan Partners Limited Partnership | $580195955 | 5441718 | 3,55% | الأسهم |
| RTW INVESTMENTS, LP | $516347866 | 4842880 | 3,16% | الأسهم |
| AMERIPRISE FINANCIAL INC | $483856150 | 4538102 | 2,96% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $389229811 | 3661786 | 2,38% | الأسهم |
| NORGES BANK | $360124083 | 3377641 | 2,20% | الأسهم |
| MAVERICK CAPITAL LTD | $229314244 | 2150762 | 1,40% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $218358293 | 2048005 | 1,34% | الأسهم |
| Qube Research & Technologies Ltd | $179370451 | 1682334 | 1,10% | الأسهم |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $173743795 | 1629561 | 1,06% | الأسهم |
| Integral Health Asset Management, LLC | $170592000 | 1600000 | 1,04% | الأسهم |
| CITADEL ADVISORS LLC | $160586566 | 1506158 | 0,98% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $149433474 | 1401552 | 0,91% | الأسهم |
| Balyasny Asset Management L.P. | $141423967 | 1326430 | 0,86% | الأسهم |
| Paradigm Biocapital Advisors LP | $141375668 | 1325977 | 0,86% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $132445710 | 1242222 | 0,81% | الأسهم |
| Pictet Asset Management Holding SA | $129804038 | 1220353 | 0,79% | الأسهم |
| D. E. Shaw & Co., Inc. | $120259044 | 1127922 | 0,74% | الأسهم |
| Hood River Capital Management LLC | $112683586 | 1056871 | 0,69% | الأسهم |
| Castle Hook Partners LP | $105906712 | 993310 | 0,65% | الأسهم |
| JENNISON ASSOCIATES LLC | $96501143 | 905094 | 0,59% | الأسهم |
| TimesSquare Capital Management, LLC | $95626169 | 584798 | 0,58% | الأسهم |
| Polar Capital Holdings Plc | $94984773 | 890872 | 0,58% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $92119680 | 864000 | 0,56% | عقد خيار الشراء |
| FIL Ltd | $91289537 | 856214 | 0,56% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $91280154 | 856126 | 0,56% | الأسهم |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $90627000 | 850000 | 0,55% | الأسهم |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84788663 | 795242 | 0,52% | الأسهم |
| GOLDMAN SACHS GROUP INC | $81873498 | 767900 | 0,50% | عقد خيار البيع |
| AMERICAN CENTURY COMPANIES INC | $81002980 | 759735 | 0,50% | الأسهم |
| Caption Management, LLC | $78973434 | 740700 | 0,48% | عقد خيار البيع |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $77763723 | 729354 | 0,48% | الأسهم |
| GOLDMAN SACHS GROUP INC | $77305085 | 725052 | 0,47% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76670442 | 719100 | 0,47% | عقد خيار البيع |
| Clearbridge Investments, LLC | $76331581 | 715922 | 0,47% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76297272 | 715600 | 0,47% | عقد خيار الشراء |
| ALLIANCEBERNSTEIN L.P. | $75676402 | 462796 | 0,46% | الأسهم |
| Ensign Peak Advisors, Inc | $74948636 | 702951 | 0,46% | الأسهم |
| Affinity Asset Advisors, LLC | $69303000 | 650000 | 0,42% | الأسهم |
| TWO SIGMA ADVISERS, LP | $68745800 | 395000 | 0,42% | الأسهم |
| Caption Management, LLC | $67170600 | 630000 | 0,41% | عقد خيار الشراء |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $67152581 | 629831 | 0,41% | الأسهم |
| Squarepoint Ops LLC | $65727392 | 616464 | 0,40% | الأسهم |
| AQR CAPITAL MANAGEMENT LLC | $65302719 | 612596 | 0,40% | الأسهم |
| Railway Pension Investments Ltd | $64473114 | 604700 | 0,39% | الأسهم |
| Swiss National Bank | $63280249 | 593512 | 0,39% | الأسهم |
| Artia Global Partners LP | $62804724 | 589052 | 0,38% | الأسهم |
| EVENTIDE ASSET MANAGEMENT, LLC | $62220874 | 583665 | 0,38% | الأسهم |
| Davern Capital Partners, LP | $59688435 | 559824 | 0,37% | الأسهم |
| Candriam S.C.A. | $59131121 | 555131 | 0,36% | الأسهم |
| Point72 Asset Management, L.P. | $57254620 | 536997 | 0,35% | الأسهم |
| Long Focus Capital Management, LLC | $56295360 | 528000 | 0,34% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49576321 | 303182 | 0,30% | الأسهم |
| BlackRock, Inc. | $49204384 | 461493 | 0,30% | الأسهم |
| Bridgewater Associates, LP | $48553895 | 455392 | 0,30% | الأسهم |
| JANE STREET GROUP, LLC | $48160254 | 451700 | 0,29% | عقد خيار الشراء |
| WELLINGTON MANAGEMENT GROUP LLP | $47494625 | 445457 | 0,29% | الأسهم |
| Sumitomo Mitsui Trust Group, Inc. | $46668960 | 437713 | 0,29% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $44365435 | 416108 | 0,27% | الأسهم |
| Palo Alto Investors LP | $44138548 | 413980 | 0,27% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $42729564 | 400765 | 0,26% | الأسهم |
| Eagle Health Investments LP | $40955941 | 384130 | 0,25% | الأسهم |
| Prosight Management, LP | $40047432 | 375609 | 0,24% | الأسهم |
| GATEWAY INVESTMENT ADVISERS LLC | $38916300 | 365000 | 0,24% | الأسهم |
| Rock Springs Capital Management LP | $38612433 | 362150 | 0,24% | الأسهم |
| CITADEL ADVISORS LLC | $38084664 | 357200 | 0,23% | عقد خيار الشراء |
| NEUBERGER BERMAN GROUP LLC | $37086246 | 347836 | 0,23% | الأسهم |
| JANE STREET GROUP, LLC | $36975816 | 346800 | 0,23% | عقد خيار البيع |
| ENVESTNET ASSET MANAGEMENT INC | $35930149 | 336997 | 0,22% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $34817934 | 326561 | 0,21% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $33116173 | 310600 | 0,20% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $33084186 | 310300 | 0,20% | عقد خيار الشراء |
| VICTORY CAPITAL MANAGEMENT INC | $32695129 | 306651 | 0,20% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $32437642 | 304236 | 0,20% | الأسهم |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $31622852 | 296594 | 0,19% | الأسهم |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30876512 | 289594 | 0,19% | الأسهم |
| Defilade Capital Management, L.P. | $30049568 | 281838 | 0,18% | الأسهم |
| SAMLYN CAPITAL, LLC | $29812765 | 279617 | 0,18% | الأسهم |
| CITADEL ADVISORS LLC | $29181894 | 273700 | 0,18% | عقد خيار البيع |
| RHUMBLINE ADVISERS | $29076813 | 272715 | 0,18% | الأسهم |
| First Turn Management, LLC | $28131794 | 263851 | 0,17% | الأسهم |
| Bank of New York Mellon Corp | $27412962 | 257109 | 0,17% | الأسهم |
| California Public Employees Retirement System | $26692317 | 250350 | 0,16% | الأسهم |
| Vestal Point Capital, LP | $26655000 | 250000 | 0,16% | الأسهم |
| Fiera Capital Corp | $26535159 | 248876 | 0,16% | الأسهم |
| TD Asset Management Inc | $25608205 | 240182 | 0,16% | الأسهم |
| Caption Management, LLC | $25162320 | 236000 | 0,15% | الأسهم |
| Trails Edge Capital Partners, LP | $24557891 | 230331 | 0,15% | الأسهم |
| ADAR1 Capital Management, LLC | $24364802 | 228520 | 0,15% | الأسهم |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23363000 | 219123 | 0,14% | الأسهم |
| Assenagon Asset Management S.A. | $23271947 | 218270 | 0,14% | الأسهم |
| DNB Asset Management AS | $22737675 | 213259 | 0,14% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $22675515 | 212676 | 0,14% | الأسهم |
| Longaeva Partners L.P. | $21454716 | 201226 | 0,13% | الأسهم |
المطلعون على الشركة 48 من المطلعين · مسؤولون 29 · مديرون 18
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 23 يوليو، 2026 M | 259058 | 0 | 67 | $-31886073 |
| Timothy Whitten | President & CEO | 1 يونيو، 2012 P | 10000 | 0 | 0 | $0 |
| Geoffrey Allan | President, CEO and Chairman | 31 مارس، 2009 M | 1715557 | 0 | 0 | $0 |
| Sara Bonstein | Chief Financial Officer | 3 يونيو، 2026 S | 69082 | 0 | 1 | $-245857 |
| Paolo Tombesi | Chief Financial Officer | 3 يناير، 2019 A | 10669 | 0 | 0 | $0 |
| Andrew T Drechsler | Chief Financial Officer | 1 مارس، 2017 M | 15000 | 0 | 0 | $0 |
| Kevin P Tully | Executive VP & CFO | 21 ديسمبر، 2011 A | 377344 | 0 | 0 | $0 |
| Steve C Glover | President Follow-on Biologics | 31 مارس، 2009 M | 372113 | 0 | 0 | $0 |
| Ronald D Gunn | Executive Vice President & COO | 8 ديسمبر، 2005 A | 40074 | 0 | 0 | $0 |
| Samuele Butera | SVP, GM, Global Respiratory | 23 يونيو، 2026 A | 7342 | 0 | 0 | $0 |
| Michael Alexander Smith | Chief Legal Officer | 22 يونيو، 2026 S | 37648 | 0 | 2 | $-393852 |
| Orlov S Nicole Schaeffer | Chief People Strategy Officer | 2 يناير، 2026 M | 41754 | 0 | 9 | $-26423350 |
| John Drayton Wise | Chief Commercial Officer | 23 مايو، 2022 A | 78137 | 0 | 0 | $0 |
| John Soriano | Chief Compliance Officer | 7 سبتمبر، 2021 M | 35204 | 0 | 0 | $0 |
| Christine A Pellizzari | Chief Legal Officer | 15 مايو، 2021 F | 149985 | 0 | 0 | $0 |
| John Goll | Chief Accounting Officer | 3 يناير، 2020 A | 14166 | 0 | 0 | $0 |
| Paul Streck | Chief Medical Officer | 8 أغسطس، 2018 A | 15996 | 0 | 0 | $0 |
| Eugene Jeffrey Sullivan | Chief Med. & Scientific Ofc. | 17 مايو، 2017 A | — | 0 | 0 | $0 |
| Mark Quigley | Vice President, Quality | 12 مايو، 2015 M | 0 | 0 | 0 | $0 |
| Peggy Berry | Vice President, Regulatory | 26 فبراير، 2015 A | — | 0 | 0 | $0 |
| Matthew Pauls | Chief Commercial Officer | 2 يونيو، 2014 A | — | 0 | 0 | $0 |
| Andrea Holtzman Drucker | SVP, Gen. Counsel & Corp Sec. | 3 يونيو، 2013 M | 45000 | 0 | 0 | $0 |
| Renu Gupta | EVP & Chief Medical Officer | 23 مايو، 2013 A | 19507 | 0 | 0 | $0 |
| Nicholas A. Labella Jr. | Chief Scientific Officer | 21 ديسمبر، 2011 A | — | 0 | 0 | $0 |
| Nicholas Lee Gurreri | Senior VP, Commercial Ops | 31 يناير، 2011 A | — | 0 | 0 | $0 |
| Doug Farrar | Vice President, ITP | 31 مارس، 2009 M | 292055 | 0 | 0 | $0 |
| Michael Duncan | Principal Financial Officer | 8 ديسمبر، 2005 A | — | 0 | 0 | $0 |
| Philip J Young | Chief Business Officer and EVP | 8 ديسمبر، 2005 A | — | 0 | 0 | $0 |
| Thomas A Keuer | Sr VP, ITP (Subsidiary) | 8 ديسمبر، 2005 A | — | 0 | 0 | $0 |
| Melvin Sharoky MD | مدير | 13 مايو، 2026 A | 246081 | 0 | 3 | $-6849100 |
| David W J Mcgirr | مدير | 9 فبراير، 2026 G | 53400 | 0 | 0 | $0 |
| Clarissa Desjardins | مدير | 11 مايو، 2022 A | 35595 | 0 | 0 | $0 |
| Elizabeth M Anderson | مدير | 11 مايو، 2022 A | 42317 | 0 | 0 | $0 |
| Leo Lee | مدير | 11 مايو، 2022 A | 53265 | 0 | 0 | $0 |
| David R Brennan | مدير | 11 مايو، 2022 A | 95521 | 0 | 0 | $0 |
| Alfred Altomari | مدير | 11 مايو، 2022 A | 43141 | 0 | 0 | $0 |
| Steinar J Engelsen | مدير | 1 نوفمبر، 2021 P | 320802 | 0 | 0 | $0 |
| Donald J Hayden JR | مدير | 9 إبريل، 2019 M | 62197 | 0 | 0 | $0 |
| Myrtle S Potter | مدير | 15 مايو، 2018 A | 25510 | 0 | 0 | $0 |
| Randall W Whitcomb | مدير | 10 مارس، 2015 M | 69188 | 0 | 0 | $0 |
| Richard S Kollender | مدير | 31 أكتوبر، 2013 M | 24598 | 0 | 0 | $0 |
| Dennis M Lanfear | مدير | 9 يونيو، 2010 A | 168404 | 0 | 0 | $0 |
| Graham K Crooke | مدير | 9 يونيو، 2010 A | 228404 | 0 | 0 | $0 |
| Kenneth G Condon | مدير | 9 يونيو، 2010 A | 168504 | 0 | 0 | $0 |
| FMR LLC | مالك 10% | 22 يوليو، 2013 S | 2221 | 0 | 0 | $0 |
| Roger Adsett | — | 10 أغسطس، 2026 M | 98744 | 0 | 2 | $-32207190 |
| Martina Flammer M.D. | — | 6 أغسطس، 2026 M | 60486 | 0 | 5 | $-5110195 |
| Carol Schafer | — | 13 مايو، 2026 A | 66622 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 121 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 3,71% | 7509 NS | 30 إبريل، 2026 | N-PORT |
| IBB · iShares Trust | 2,19% | 1576476 SH | 8 أغسطس، 2026 | يومي |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,94% | 11797 SH | 8 أغسطس، 2026 | يومي |
| FMED · Fidelity Covington Trust | 1,79% | 6875 NS | 31 مايو، 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,70% | 15835 NS | 31 مايو، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,44% | 92576 NS | 30 إبريل، 2026 | N-PORT |
| BIB · ProShares Trust | 1,16% | 7968 NS | 31 مايو، 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,11% | 2081 NS | 31 مايو، 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,10% | 4801 NS | 30 إبريل، 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 1,06% | 2228 NS | 30 إبريل، 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,92% | 34830 NS | 30 إبريل، 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,90% | 80500 NS | 30 إبريل، 2026 | N-PORT |
| IWP · iShares Trust | 0,81% | 1239854 SH | 8 أغسطس، 2026 | يومي |
| HRTS · Tema ETF Trust | 0,71% | 3449 NS | 31 مايو، 2026 | N-PORT |
| LFSC · RBB Fund, Inc. | 0,62% | 6050 NS | 31 مايو، 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 35661 NS | 30 إبريل، 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,50% | 40138 NS | 30 إبريل، 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,47% | 98313 NS | 30 إبريل، 2026 | N-PORT |
| IYH · iShares Trust | 0,46% | 128330 SH | 8 أغسطس، 2026 | يومي |
| FFSM · FIDELITY COVINGTON TRUST | 0,40% | 37505 NS | 30 إبريل، 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,39% | 36063 NS | 30 إبريل، 2026 | N-PORT |
| SMLF · iShares Trust | 0,39% | 123385 SH | 8 أغسطس، 2026 | يومي |
| IMCG · iShares Trust | 0,38% | 116453 SH | 8 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,33% | 632581 SH | 8 أغسطس، 2026 | يومي |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 1435651 SH | 8 أغسطس، 2026 | يومي |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 695 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,26% | 2487127 SH | 8 أغسطس، 2026 | يومي |
| VOT · VANGUARD INDEX FUNDS | 0,25% | 830249 SH | 8 أغسطس، 2026 | يومي |
| FDG · AMERICAN CENTURY ETF TRUST | 0,24% | 9338 NS | 31 مايو، 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 7501 SH | 8 أغسطس، 2026 | يومي |
| FFLG · FIDELITY COVINGTON TRUST | 0,22% | 9640 NS | 30 إبريل، 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,22% | 31591 SH | 8 أغسطس، 2026 | يومي |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,21% | 22539 NS | 30 إبريل، 2026 | N-PORT |
| ESLV · Strategy Shares | 0,20% | 176 NS | 30 إبريل، 2026 | N-PORT |
| IWR · iShares Trust | 0,20% | 873374 SH | 8 أغسطس، 2026 | يومي |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 32329 NS | 30 إبريل، 2026 | N-PORT |
| ESLG · Strategy Shares | 0,20% | 279 NS | 30 إبريل، 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,19% | 6824 NS | 30 إبريل، 2026 | N-PORT |
| IMCB · iShares Trust | 0,19% | 24582 SH | 8 أغسطس، 2026 | يومي |
| ESUM · Strategy Shares | 0,19% | 2146 NS | 30 إبريل، 2026 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0,17% | 3643 NS | 30 إبريل، 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,16% | 155 NS | 31 مايو، 2026 | N-PORT |
| QYLD · Global X Funds | 0,16% | 98226 NS | 30 إبريل، 2026 | N-PORT |
| QCLR · Global X Funds | 0,15% | 45 NS | 30 إبريل، 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 1572 NS | 30 إبريل، 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 32 NS | 30 إبريل، 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,15% | 24910 NS | 31 مايو، 2026 | N-PORT |
| QRMI · Global X Funds | 0,15% | 174 NS | 30 إبريل، 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,14% | 13104 NS | 30 إبريل، 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 2485842 SH | 8 أغسطس، 2026 | يومي |